Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 3/20 | 0.58 |
| ▸ | KISS1R | Q969F8 | 4/20 | 0.58 |
| ▸ | IL23R | Q5VWK5 | 9/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24062383 | 0.88 | KISS1R (0.55) | GHSRKISS1RIL23R | |
| SCHEMBL21664095 | 0.87 | GHSR (0.62) | GHSRKISS1RIL23R | |
| SCHEMBL29351915 | 0.85 | KISS1R (0.64) | GHSRKISS1RIL23R | |
| SCHEMBL29550696 | 0.85 | GHSR (0.67) | GHSRKISS1R | |
| SCHEMBL30297534 | 0.85 | GHSR (0.69) | GHSRKISS1RIL23R | |
| SCHEMBL14922491 | 0.83 | GHSR (0.77) | GHSR | |
| SCHEMBL30276253 | 0.83 | GHSR (0.64) | GHSRKISS1RIL23R | |
| SCHEMBL29551293 | 0.83 | GHSR (0.64) | GHSRKISS1RIL23R | |
| SCHEMBL30490003 | 0.82 | GHSR (0.65) | GHSRKISS1R | |
| SCHEMBL30276276 | 0.82 | GHSR (0.63) | GHSRKISS1RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | FUJIFILM CORPORATION (JP) | 2022-05-03 | — | — | US | disclosed |
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | FUJIFILM CORPORATION (JP) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200040039-A1 | PEPTIDE COMPOUND AND METHOD FOR PRODUCING SAME, COMPOSITION FOR SCREENING USE, AND METHOD FOR SELECTING PEPTIDE COMPOUND | VIP, NPPA, NGLY1 | GHSR 693/4885KISS1R 375/4885IL23R 4063/4885 |
| US-11319347-B2 | Peptide compound and method for producing same, composition for screening use, and method for selecting peptide compound | VIP, NPPA, NGLY1 | GHSR 693/4885KISS1R 375/4885IL23R 4063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.